查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790775

2025年全球生醫材料市場報告

Biomaterials Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年生醫材料市場將快速成長，到 2029 年將達到 2,524.1 億美元，年複合成長率（CAGR）為 13.6%。預測期內的成長動力包括消費者偏好的變化、3D 列印和積層製造對生醫材料需求的激增、生物分解性分解和生物可吸收生醫材料領域的擴張、個人化醫療藥物輸送系統中生醫材料的採用，以及生醫材料在傷口護理和組織再生中的應用日益增多。預測期內的主要趨勢包括響應性和適應性智慧生醫材料的開發、奈米技術的整合以改進功能、專注於精準醫療從而提供客製化的生醫材料解決方案、探索海洋和植物來源生醫材料來源，以及生醫材料公司與醫療機構之間在創新應用方面的合作。

未來五年預測成長率為13.6%，較我們先前對該市場的預測略有下降0.7%。這一下降主要源自於美國與其他國家之間關稅的影響。由於從瑞士和以色列進口的專業生醫材料面臨越來越多的貿易壁壘，從而推高了醫療創新的成本，這可能會導致醫療設備製造和組織工程計劃的延誤，從而直接影響美國。此外，由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，影響也將更加廣泛。

心血管疾病的日益普及推動了生醫材料市場的擴張。心血管疾病的發生可歸因於高血壓、吸菸、高膽固醇和缺乏運動等因素。心血管疾病患者的增加主要是由於糖尿病、慢性呼吸系統疾病、冠狀動脈疾病 (CAD) 以及與高血壓相關的心臟病發作等非傳染性疾病。心臟瓣膜、心肺體外迴圈系統、支架、血管移植物、全人工心臟和心律調節器等生醫材料可作為受損或患病心臟組織的修復機制。例如，根據美國政府機構疾病管制與預防中心 (CDC) 2024 年 5 月的數據，2022 年美國將有 702,880 人死於心臟病，其中 371,506 人死於冠狀動脈疾病。因此，心血管疾病盛行率的上升預計將推動生醫材料市場的需求。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球生醫材料：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球生醫材料市場：成長率分析
  • 全球生醫材料市場表現：規模與成長，2019-2024
  • 全球生醫材料市場預測：2024-2029年、2034年規模與成長
  • 全球生醫材料：總目標市場（TAM）

第6章市場區隔

  • 全球生醫材料市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 金屬生醫材料
  • 聚合物生醫材料
  • 天然生醫材料
  • 陶瓷
  • 全球生醫材料市場（依應用）表現及預測（2019-2024、2024-2029、2034）
  • 心血管系統
  • 整形外科
  • 眼科
  • 牙科
  • 整形外科
  • 傷口癒合
  • 組織工程
  • 神經系統/中樞神經系統
  • 全球生醫材料市場最終用途、性能及預測（2019-2024、2024-2029、2034）
  • 醫院和診所
  • 門診手術中心
  • 其他最終用戶
  • 全球生醫材料市場，按金屬生醫材料類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 不銹鋼
  • 鈦合金
  • 鈷鉻合金
  • 鎂合金
  • 全球生醫材料市場，按聚合物生醫材料類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 合成聚合物
  • 天然聚合物
  • 生物分解性聚合物
  • 全球生醫材料市場，依天然生醫材料類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 動物源性材料
  • 植物來源材料
  • 全球生醫材料市場、陶瓷細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 生物陶瓷
  • 多孔陶瓷
  • 無孔陶瓷

第7章 區域和國家分析

  • 全球生醫材料市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球生醫材料市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 生醫材料市場：競爭格局
  • 生醫材料市場：公司簡介
    • Corbion NV Overview, Products and Services, Strategy and Financial Analysis
    • Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
    • Heraeus Medical Components LLC Overview, Products and Services, Strategy and Financial Analysis
    • Berkeley Advanced Biomaterials Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • DSM Biomedical BV
  • PolyNovo Limited
  • Baxter International Inc.
  • Stryker Corporation
  • Collagen Solutions plc
  • Invibio Ltd.
  • Aap Implantate AG
  • Cam Bioceramics BV
  • CeramTec GmbH
  • CoorsTek Medical LLC
  • CryoLife Inc.
  • Cerapedics Inc.
  • Surmodics Inc.
  • Secant Group LLC
  • GELITA AG

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年生醫材料市場：提供新機會的國家
  • 2029年生醫材料市場：細分領域帶來新機會
  • 2029年生醫材料市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r21147u

The biomaterials refer to manmade substances that can be utilized to support tissues or structures in the body. These are natural or synthetic materials that are used in medical applications to support, enhance, or replace damaged tissue or a biological function.

The main types of biomaterials are metallic biomaterial, polymeric biomaterials, natural biomaterials and ceramics. The metallic biomaterials are stainless steels, titanium alloys, and cobalt alloys used to provide internal support to biological tissues. The metallic biomaterials are manmade systems that are utilized in joint replacements, dental implants, orthopedic fixations, and stents to offer internal support to biological tissues. Biomaterials have a wide application in cardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering and neurological/central nervous system and are used in hospitals and clinics, ambulatory surgical centers and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the metals and minerals sector, disrupting supply chains for automakers, appliance manufacturers, and infrastructure projects. With reduced competition from imports, domestic mills have increased prices, yet capacity limitations hinder their ability to fully meet demand. At the same time, mining companies are facing challenges from retaliatory tariffs on key mineral exports, especially lithium and rare earth elements. In response, industry participants are ramping up investments in scrap metal recycling, seeking tariff exemptions, and forming joint ventures with international producers to ensure a more reliable supply chain.

The biomaterials market research report is one of a series of new reports from The Business Research Company that provides biomaterials market statistics, including biomaterials industry global market size, regional shares, competitors with a biomaterials market share, detailed biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the biomaterials industry. This biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biomaterials market size has grown rapidly in recent years. It will grow from $134.31 billion in 2024 to $151.47 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to growing aging population, adoption of biomaterials in orthopedic and dental applications, increasing awareness of environmental sustainability, increased prevalence of chronic conditions medicine, increased demand for medical implants.

The biomaterials market size is expected to see rapid growth in the next few years. It will grow to $252.41 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to shifting consumer preferences, surge in demand for biomaterials in 3d printing and additive manufacturing, expansion of the biodegradable and bioresorbable biomaterials segment, adoption of biomaterials in drug delivery systems for personalized medicine, increasing use of biomaterials in wound care and tissue regeneration. Major trends in the forecast period include development of smart biomaterials with responsive and adaptive properties, integration of nanotechnology for enhanced functionality, emphasis on precision medicine leading to customized biomaterial solutions, exploration of marine and plant-derived biomaterial sources, collaboration between biomaterial companies and healthcare institutions for innovative applications.

The forecast of 13.6% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through delays in medical device manufacturing and tissue engineering projects, as specialized biomaterial imports from Switzerland and Israel face increased trade barriers, raising costs for healthcare innovation. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of cardiovascular diseases is propelling the expansion of the biomaterials market. Cardiovascular disorders stem from factors such as high blood pressure, smoking, high cholesterol, and inactivity. The rise in cardiovascular disorder cases is largely attributed to noncommunicable diseases like diabetes, chronic respiratory illnesses, coronary artery disease (CAD), and heart attacks related to hypertension. Biomaterials, including heart valves, cardiopulmonary bypass systems, stents, vascular grafts, complete artificial hearts, and pacemakers, serve as healing mechanisms for damaged and diseased heart tissue. For instance, data from the Centers for Disease Control and Prevention (CDC), a US government agency, indicated in May 2024 that there were 702,880 deaths from heart disease in the United States in 2022, with 371,506 of those attributable to coronary artery disease. Consequently, the rising incidence of cardiovascular diseases is expected to boost the demand for the biomaterials market.

The increasing healthcare spending will propel the growth of the biomaterials market. Healthcare spending refers to the total financial resources allocated for medical services, treatments, and healthcare infrastructure within a given period, typically on a national or institutional level. Healthcare spending is used in biomaterials for research and development, product development, procurement and adoption, and regulatory compliance. For instance, in September 2022, according to MedTech Europe, a Belgium-based European trade association representing the medical technology industries, in Europe, on average, approximately 11% of gross domestic product (GDP) is allocated to healthcare. Out of this, about 7. 6% is attributed to medical technologies. The spending on medical technology across European countries ranges from around 5% to 12% of the total healthcare expenditure. The per capita expenditure on medical technology in Europe stands at approximately $346. 08 (€284). Therefore, increasing healthcare spending will contribute to the growth of the biomaterials market.

Strategic partnerships are emerging as a significant trend in the biomaterials market. Leading companies are increasingly focusing on collaborations to develop new implants and combination devices based on biomaterials, leveraging each other's expertise, technology, and resources. These partnerships also aim to boost the adoption of biomaterials. By joining forces, companies can gain a competitive advantage in the market and enhance revenue. For example, in June 2023, IFF, a US-based corporation, launched the Designed Enzymatic Biomaterials (DEB) technology platform to meet the rising demand for sustainable, high-performance materials. This platform enables precise drug delivery through engineered enzymes that release therapeutic agents in response to specific biological cues. It is also vital in tissue engineering, where enzymatic reactions promote tissue regeneration by facilitating cell growth and allowing controlled degradation of scaffolds at predetermined rates. The DEB technology enables the customization of biobased polysaccharides that can match or surpass the performance of traditional petroleum-based polymers, thereby facilitating greater market adoption.

Major companies operating in the biomaterials market focus on technological advancements, such as the designed enzymatic biomaterials (DEB) technology platform, to deliver sustainable biopolymers and gain a competitive advantage. The enzymatic biomaterials (DEB) technology platform involves the use of enzymes to design and modify materials for various applications, including drug delivery, tissue engineering, and diagnostics. For instance, in June 2023, International Flavors & Fragrances Inc., a US-based producer of flavors, fragrances, and cosmetic actives, launched the enzymatic biomaterials technology platform for the development of biobased materials at scale. Designed to deliver meaningful sustainability benefits with performance comparable to or superior to fossil-based materials, DEB technology helps to address growing preferences for environmentally friendly, high-performance biopolymers. The technology platform allows producers to fulfill regulatory changes and increasing consumer demand by replacing traditional fossil-based synthetic polymers.

In October 2024, RTI Surgical (RTI), a US-based medical equipment manufacturing company, acquired Collagen Solutions plc for an undisclosed amount. The objective of RTI Surgical's acquisition of Collagen Solutions is to broaden its soft tissue portfolio and improve its capabilities in the regenerative medicine sector. Collagen Solutions plc is a US-based supplier, developer, and manufacturer of medical-grade collagen, tissues, and other biomaterials for use in regenerative medicine, medical devices, and research.

Major companies operating in the biomaterials market include Corbion N V, Evonik Industries AG, Heraeus Medical Components LLC, Berkeley Advanced Biomaterials Inc., Zimmer Biomet Holdings Inc., DSM Biomedical BV, PolyNovo Limited, Baxter International Inc., Stryker Corporation, Collagen Solutions plc, Invibio Ltd., Aap Implantate AG, Cam Bioceramics BV, CeramTec GmbH, CoorsTek Medical LLC, CryoLife Inc., Cerapedics Inc., Surmodics Inc., Secant Group LLC, GELITA AG, Quattroflow GmbH, Kyocera Corporation, Wright Medical Group NV, KLS Martin Group GmbH & Co KG, Meccellis Biotechnology Co Ltd., Bio-on SpA, Coloplast A/S, Collagen Matrix Inc., IntrinsiQ Materials Inc., PolyActiva Pty Ltd

North America was the largest region in the biomaterials market in 2024. The regions covered in the biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The biomaterials market consists of sales of metals, polymers, and composites. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biomaterials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biomaterials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Metallic Biomaterial; Polymeric Biomaterials; Natural Biomaterials; Ceramics
  • 2) By Application: Cardiovascular; Orthopedic; Ophthalmology; Dental; Plastic Surgery; Wound Healing; Tissue Engineering; Neurological/Central Nervous System
  • 3) By End Use: Hospitals And Clinics; Ambulatory Surgical Centers; Other End Users
  • Subsegments:
  • 1) By Metallic Biomaterials: Stainless Steel; Titanium Alloys; Cobalt-Chromium Alloys; Magnesium Alloys
  • 2) By Polymeric Biomaterials: Synthetic Polymers; Natural Polymers; Biodegradable Polymers
  • 3) By Natural Biomaterials: Animal-Derived Materials; Plant-Derived Materials
  • 4) By Ceramics: Bioceramics; Porous Ceramics; Non-porous Ceramics
  • Companies Mentioned: Corbion N V; Evonik Industries AG; Heraeus Medical Components LLC; Berkeley Advanced Biomaterials Inc.; Zimmer Biomet Holdings Inc.; DSM Biomedical BV; PolyNovo Limited; Baxter International Inc.; Stryker Corporation; Collagen Solutions plc; Invibio Ltd.; Aap Implantate AG; Cam Bioceramics BV; CeramTec GmbH; CoorsTek Medical LLC; CryoLife Inc.; Cerapedics Inc.; Surmodics Inc.; Secant Group LLC; GELITA AG; Quattroflow GmbH; Kyocera Corporation; Wright Medical Group NV; KLS Martin Group GmbH & Co KG; Meccellis Biotechnology Co Ltd.; Bio-on SpA; Coloplast A/S; Collagen Matrix Inc.; IntrinsiQ Materials Inc.; PolyActiva Pty Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biomaterials Market Characteristics

3. Biomaterials Market Trends And Strategies

4. Biomaterials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biomaterials Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Biomaterials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Biomaterials Market Growth Rate Analysis
  • 5.4. Global Biomaterials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Biomaterials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Biomaterials Total Addressable Market (TAM)

6. Biomaterials Market Segmentation

  • 6.1. Global Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metallic Biomaterial
  • Polymeric Biomaterials
  • Natural Biomaterials
  • Ceramics
  • 6.2. Global Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Plastic Surgery
  • Wound Healing
  • Tissue Engineering
  • Neurological/Central Nervous System
  • 6.3. Global Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Other End Users
  • 6.4. Global Biomaterials Market, Sub-Segmentation Of Metallic Biomaterials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stainless Steel
  • Titanium Alloys
  • Cobalt-Chromium Alloys
  • Magnesium Alloys
  • 6.5. Global Biomaterials Market, Sub-Segmentation Of Polymeric Biomaterials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Synthetic Polymers
  • Natural Polymers
  • Biodegradable Polymers
  • 6.6. Global Biomaterials Market, Sub-Segmentation Of Natural Biomaterials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Animal-Derived Materials
  • Plant-Derived Materials
  • 6.7. Global Biomaterials Market, Sub-Segmentation Of Ceramics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bioceramics
  • Porous Ceramics
  • Non-porous Ceramics

7. Biomaterials Market Regional And Country Analysis

  • 7.1. Global Biomaterials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Biomaterials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biomaterials Market

  • 8.1. Asia-Pacific Biomaterials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biomaterials Market

  • 9.1. China Biomaterials Market Overview
  • 9.2. China Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biomaterials Market

  • 10.1. India Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biomaterials Market

  • 11.1. Japan Biomaterials Market Overview
  • 11.2. Japan Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biomaterials Market

  • 12.1. Australia Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biomaterials Market

  • 13.1. Indonesia Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biomaterials Market

  • 14.1. South Korea Biomaterials Market Overview
  • 14.2. South Korea Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biomaterials Market

  • 15.1. Western Europe Biomaterials Market Overview
  • 15.2. Western Europe Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biomaterials Market

  • 16.1. UK Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biomaterials Market

  • 17.1. Germany Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biomaterials Market

  • 18.1. France Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biomaterials Market

  • 19.1. Italy Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biomaterials Market

  • 20.1. Spain Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biomaterials Market

  • 21.1. Eastern Europe Biomaterials Market Overview
  • 21.2. Eastern Europe Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biomaterials Market

  • 22.1. Russia Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biomaterials Market

  • 23.1. North America Biomaterials Market Overview
  • 23.2. North America Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biomaterials Market

  • 24.1. USA Biomaterials Market Overview
  • 24.2. USA Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biomaterials Market

  • 25.1. Canada Biomaterials Market Overview
  • 25.2. Canada Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biomaterials Market

  • 26.1. South America Biomaterials Market Overview
  • 26.2. South America Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biomaterials Market

  • 27.1. Brazil Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biomaterials Market

  • 28.1. Middle East Biomaterials Market Overview
  • 28.2. Middle East Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biomaterials Market

  • 29.1. Africa Biomaterials Market Overview
  • 29.2. Africa Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biomaterials Market Competitive Landscape And Company Profiles

  • 30.1. Biomaterials Market Competitive Landscape
  • 30.2. Biomaterials Market Company Profiles
    • 30.2.1. Corbion N V Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Heraeus Medical Components LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Berkeley Advanced Biomaterials Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Biomaterials Market Other Major And Innovative Companies

  • 31.1. DSM Biomedical BV
  • 31.2. PolyNovo Limited
  • 31.3. Baxter International Inc.
  • 31.4. Stryker Corporation
  • 31.5. Collagen Solutions plc
  • 31.6. Invibio Ltd.
  • 31.7. Aap Implantate AG
  • 31.8. Cam Bioceramics BV
  • 31.9. CeramTec GmbH
  • 31.10. CoorsTek Medical LLC
  • 31.11. CryoLife Inc.
  • 31.12. Cerapedics Inc.
  • 31.13. Surmodics Inc.
  • 31.14. Secant Group LLC
  • 31.15. GELITA AG

32. Global Biomaterials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biomaterials Market

34. Recent Developments In The Biomaterials Market

35. Biomaterials Market High Potential Countries, Segments and Strategies

  • 35.1 Biomaterials Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Biomaterials Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Biomaterials Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer